ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham(Newcastle University), Emma Scott(Newcastle University)Communications BiologyMarch 6, 202410.1038/s42003-024-05924-0Cited by 31SaveCiteExport RISWatch citationsRelated PapersA 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.|PubMed|1979|116